LU86383A1 - Solutions a base de phenytoine,leur procede de preparation et leur application pharmaceutique - Google Patents
Solutions a base de phenytoine,leur procede de preparation et leur application pharmaceutique Download PDFInfo
- Publication number
- LU86383A1 LU86383A1 LU86383A LU86383A LU86383A1 LU 86383 A1 LU86383 A1 LU 86383A1 LU 86383 A LU86383 A LU 86383A LU 86383 A LU86383 A LU 86383A LU 86383 A1 LU86383 A1 LU 86383A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- sodium
- solution
- phenytotne
- phenytoin
- chollne
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/735,932 US4642316A (en) | 1985-05-20 | 1985-05-20 | Parenteral phenytoin preparations |
US73593285 | 1985-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU86383A1 true LU86383A1 (fr) | 1986-09-02 |
Family
ID=24957819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU86383A LU86383A1 (fr) | 1985-05-20 | 1986-04-01 | Solutions a base de phenytoine,leur procede de preparation et leur application pharmaceutique |
Country Status (18)
Country | Link |
---|---|
US (1) | US4642316A (it) |
JP (1) | JPS61268618A (it) |
AU (1) | AU595790B2 (it) |
BE (1) | BE904476A (it) |
CA (1) | CA1268119A (it) |
CH (1) | CH668594A5 (it) |
DE (1) | DE3610330A1 (it) |
DK (1) | DK100786A (it) |
ES (1) | ES8707195A1 (it) |
FR (1) | FR2581871B1 (it) |
GB (1) | GB2175203B (it) |
IT (1) | IT1190282B (it) |
LU (1) | LU86383A1 (it) |
NL (1) | NL8600899A (it) |
NZ (1) | NZ215783A (it) |
PH (1) | PH22922A (it) |
SE (1) | SE8600998L (it) |
ZA (1) | ZA862094B (it) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3828156A1 (de) * | 1988-08-19 | 1990-02-22 | Astrapin Pharmazeutische Praep | Stabile waessrige loesung von fluorouracil |
WO1999004798A1 (en) * | 1997-07-22 | 1999-02-04 | Warner-Lambert Company | Lyophilized fosphenytoin sodium for parenteral use |
WO1999048876A1 (en) | 1998-03-20 | 1999-09-30 | Warner-Lambert Company | Crystalline sodium phenytoin monohydrate |
US6274168B1 (en) | 1999-02-23 | 2001-08-14 | Mylan Pharmaceuticals Inc. | Phenytoin sodium pharmaceutical compositions |
AU2003288588A1 (en) * | 2002-12-16 | 2004-07-09 | Ranbaxy Laboratories Limited | An extended release pharmaceutical composition of phenytoin sodium |
NZ599464A (en) | 2005-02-03 | 2014-03-28 | Topotarget Uk Ltd | Combination therapies using hdac inhibitors |
DE102005019393A1 (de) * | 2005-04-25 | 2006-10-26 | Basell Polyolefine Gmbh | Polyethylenformmassen für Spritzgussanwendungen |
ES2380887T3 (es) | 2005-05-13 | 2012-05-21 | Topotarget Uk Limited | Formulaciones farmacéuticas de inhibidores de la HDAC |
AU2012213940B2 (en) * | 2005-05-13 | 2015-03-26 | Topotarget Uk Limited | Pharmaceutical formulations of HDAC inhibitors |
EP1957056A2 (en) * | 2005-11-10 | 2008-08-20 | TopoTarget UK Limited | Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
US8377979B2 (en) * | 2005-12-05 | 2013-02-19 | Taro Pharmaceuticals North America, Inc. | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
CA2700173C (en) * | 2007-09-25 | 2016-10-11 | Topotarget Uk Limited | Methods of synthesis of certain hydroxamic acid compounds |
PL2262493T3 (pl) * | 2008-03-07 | 2015-08-31 | Onxeo Dk Branch Of Onxeo S A France | Sposoby leczenia wykorzystujące wydłużony ciągły wlew belinostatu |
GB0900555D0 (en) * | 2009-01-14 | 2009-02-11 | Topotarget As | New methods |
EP3777839A1 (en) | 2009-05-19 | 2021-02-17 | Neuroderm Ltd | Compositions for continuous administration of dopa decarboxylase inhibitors |
SI2640358T1 (en) | 2010-11-15 | 2018-05-31 | Neuroderm Ltd. | Continuous administration of L-dopa, dopamine decarboxylase inhibitors, catechol-O-methyl transferase inhibitors, and compositions thereof |
US9540330B2 (en) | 2010-12-15 | 2017-01-10 | Nektar Therapeutics | Oligomer-containing hydantoin compounds |
MX2014014902A (es) | 2012-06-05 | 2015-03-04 | Neuroderm Ltd | Composiciones que comprenden apomorfina y acidos organicos y usos de las mismas. |
CN106413754B (zh) | 2014-03-13 | 2019-11-29 | 纽罗德姆有限公司 | 多巴脱羧酶抑制剂组合物 |
US10258585B2 (en) | 2014-03-13 | 2019-04-16 | Neuroderm, Ltd. | DOPA decarboxylase inhibitor compositions |
US11213502B1 (en) | 2020-11-17 | 2022-01-04 | Neuroderm, Ltd. | Method for treatment of parkinson's disease |
US11844754B2 (en) | 2020-11-17 | 2023-12-19 | Neuroderm, Ltd. | Methods for treatment of Parkinson's disease |
US11331293B1 (en) | 2020-11-17 | 2022-05-17 | Neuroderm, Ltd. | Method for treatment of Parkinson's disease |
WO2023205615A1 (en) * | 2022-04-18 | 2023-10-26 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions & methods of their use |
US12109303B2 (en) | 2022-04-18 | 2024-10-08 | ISHA Therapeutics LLC | Orally dissolving antimicrobial film compositions and methods of their use |
US12161612B2 (en) | 2023-04-14 | 2024-12-10 | Neuroderm, Ltd. | Methods and compositions for reducing symptoms of Parkinson's disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3749779A (en) * | 1970-08-27 | 1973-07-31 | American Home Prod | Stable solutions of sodium diphenylhydantoin |
JPS5221575B2 (it) * | 1972-03-18 | 1977-06-11 | ||
US4163058A (en) * | 1977-04-22 | 1979-07-31 | Interx Research Corporation | Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof |
US4260769A (en) * | 1977-04-22 | 1981-04-07 | Interx Research Corporation | 5,5-Diphenylhydantoins |
-
1985
- 1985-05-20 US US06/735,932 patent/US4642316A/en not_active Expired - Fee Related
-
1986
- 1986-03-05 DK DK100786A patent/DK100786A/da not_active Application Discontinuation
- 1986-03-05 SE SE8600998A patent/SE8600998L/ not_active Application Discontinuation
- 1986-03-07 AU AU54412/86A patent/AU595790B2/en not_active Ceased
- 1986-03-13 CH CH1036/86A patent/CH668594A5/fr not_active IP Right Cessation
- 1986-03-20 ZA ZA862094A patent/ZA862094B/xx unknown
- 1986-03-20 FR FR868603981A patent/FR2581871B1/fr not_active Expired - Fee Related
- 1986-03-24 BE BE6/48212A patent/BE904476A/fr not_active IP Right Cessation
- 1986-03-25 GB GB08607383A patent/GB2175203B/en not_active Expired
- 1986-03-25 JP JP61065013A patent/JPS61268618A/ja active Pending
- 1986-03-26 DE DE19863610330 patent/DE3610330A1/de not_active Withdrawn
- 1986-04-01 LU LU86383A patent/LU86383A1/fr unknown
- 1986-04-09 NL NL8600899A patent/NL8600899A/nl not_active Application Discontinuation
- 1986-04-10 NZ NZ215783A patent/NZ215783A/xx unknown
- 1986-04-17 CA CA000506895A patent/CA1268119A/en not_active Expired - Fee Related
- 1986-04-24 IT IT47936/86A patent/IT1190282B/it active
- 1986-05-05 PH PH33734A patent/PH22922A/en unknown
- 1986-05-20 ES ES555143A patent/ES8707195A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK100786D0 (da) | 1986-03-05 |
FR2581871B1 (fr) | 1990-05-11 |
DK100786A (da) | 1986-11-21 |
SE8600998D0 (sv) | 1986-03-05 |
SE8600998L (sv) | 1986-11-21 |
ZA862094B (en) | 1986-11-26 |
CA1268119A (en) | 1990-04-24 |
NL8600899A (nl) | 1986-12-16 |
US4642316A (en) | 1987-02-10 |
DE3610330A1 (de) | 1986-11-20 |
NZ215783A (en) | 1989-01-27 |
GB2175203B (en) | 1988-09-14 |
GB8607383D0 (en) | 1986-04-30 |
ES8707195A1 (es) | 1987-07-16 |
AU5441286A (en) | 1986-11-27 |
JPS61268618A (ja) | 1986-11-28 |
BE904476A (fr) | 1986-09-24 |
GB2175203A (en) | 1986-11-26 |
IT1190282B (it) | 1988-02-16 |
IT8647936A0 (it) | 1986-04-24 |
AU595790B2 (en) | 1990-04-12 |
CH668594A5 (fr) | 1989-01-13 |
ES555143A0 (es) | 1987-07-16 |
PH22922A (en) | 1989-01-24 |
FR2581871A1 (fr) | 1986-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU86383A1 (fr) | Solutions a base de phenytoine,leur procede de preparation et leur application pharmaceutique | |
CA2102778C (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
CN1079668C (zh) | 注射用脂质体药物制剂 | |
FR2466248A1 (fr) | Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant | |
CN101621997B (zh) | 医药组合物 | |
EP0835140B1 (fr) | Complexes metalliques de polyaminoacides et leur utilisation en imagerie diagnostique | |
KR101443826B1 (ko) | 의약조성물 | |
FR2584405A1 (fr) | Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation | |
CA1281650C (en) | Aqueous preparation containing cyclodextrin | |
EP0099799B1 (fr) | Nouveaux sels d'amino- (et imino-) acides alpha, omega-sulfoniques N-substitués, vecteurs cationiques de haute pénétration cellulaire, procédé d'obtention | |
JP3917820B2 (ja) | オザグレルナトリウム含有注射液およびその安定化方法 | |
EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
RU2313346C2 (ru) | Фармацевтическая композиция | |
FR2690340A1 (fr) | Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant. | |
FR2535205A1 (fr) | Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation | |
JP2007106736A (ja) | 注射用の医薬組成物 | |
JP2007191417A (ja) | 医薬用の組成物 | |
Cavallito et al. | Complexation of ammonium salts with phenols | |
JP2003063963A (ja) | オザグレルナトリウム含有注射液 | |
LU83081A1 (fr) | Compositions antitumeurs | |
BE887220A (fr) | Compositions antitumeurs | |
JP2007077060A (ja) | 注射用の医薬組成物 | |
FR2803515A1 (fr) | Solution aqueuse stable de deoxyfructosazine | |
JP2007091674A (ja) | 注射用の医薬組成物 |